We propose that germline ERBB2 variants belong to a class of susceptibility variant that falls in between very rare variants with high disease penetrance (i.e., TP53 variants in Li–Fraumeni syndrome, or BRCA1 variants in breast and ovarian cancer), and common but low-risk susceptibility alleles detected via GWAS. Here, ERBB2 is linked to ovarian carcinoma.